SCHEMBL652703

SCHEMBL652703

CCCCn1c(-c2c(C)cccc2C)nc(Cl)c1CN(CCOC)Cc1ccc2[nH]ncc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 4/20 0.35
ROCK1 Q13464 2/20 0.35
PLK4 O00444 1/20 0.35
AURKA O14965 1/20 0.35
RPS6KA5 O75582 1/20 0.35
PRKD3 O94806 1/20 0.35
CDK1 P06493 1/20 0.35
PIM1 P11309 1/20 0.35
PRKACA P17612 1/20 0.35
CDK2 P24941 1/20 0.35
MARK3 P27448 1/20 0.35
MAPK1 P28482 1/20 0.35
AKT1 P31749 1/20 0.35
CLK2 P49760 1/20 0.35
GSK3A P49840 1/20 0.35
GSK3B P49841 1/20 0.35
IRAK1 P51617 1/20 0.35
RPS6KA3 P51812 1/20 0.35
PRKX P51817 1/20 0.35
CSNK1G2 P78368 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1913118 0.86 MAPK1 (0.37) ROCK2ROCK1PLK4AURKARPS6KA5
SCHEMBL650190 0.80 ROCK2 (0.38) ROCK2ROCK1TRPA1
SCHEMBL650605 0.80 TRPA1 (0.38) ROCK2ROCK1PLK4AURKARPS6KA5
SCHEMBL652764 0.80 TRPA1 (0.38) ROCK2ROCK1GSK3AGSK3BPRKG1
SCHEMBL648229 0.78 TRPA1 (0.39) ROCK2ROCK1S1PR1TRPA1MEN1
SCHEMBL648637 0.73 C5AR1 (0.49) ROCK2PIM1PRKACACDK2MAPK1
SCHEMBL649555 0.71 SMN1; SMN2 (0.35) MAPK1CRHR1CYP2D6
SCHEMBL650098 0.71 MEN1 (0.36) CRHR1MEN1KMT2A
SCHEMBL650038 0.70 C5AR1 (0.52) MAPK1CYP2D6
SCHEMBL649322 0.69 SQLE (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed
US-7186734-B2 Aryl imidazoles and related compounds as C5a receptor modulators NEUROGEN CORPORATION (US) 2007-03-06 US disclosed